Igs offer a versatile template for combinatorial and rational design approaches to the de novo creation of catalytically active proteins. We have used a covalent capture selection strategy to identify biocatalysts from within a human semisynthetic antibody variable fragment library that uses a nucleophilic mechanism. Specific phosphonylation at a single tyrosine within the variable light-chain framework was confirmed in a recombinant IgG construct. Highresolution crystallographic structures of unmodified and phosphonylated Fabs display a 15-Å-deep two-chamber cavity at the interface of variable light (V L ) and variable heavy (V H ) fragments having a nucleophilic tyrosine at the base of the site. The depth and structure of the pocket are atypical of antibodies in general but can be compared qualitatively with the catalytic site of cholinesterases. A structurally disordered heavy chain complementary determining region 3 loop, constituting a wall of the cleft, is stabilized after covalent modification by hydrogen bonding to the phosphonate tropinol moiety. These features and presteady state kinetics analysis indicate that an induced fit mechanism operates in this reaction. Mutations of residues located in this stabilized loop do not interfere with direct contacts to the organophosphate ligand but can interrogate second shell interactions, because the H3 loop has a conformation adjusted for binding. Kinetic and thermodynamic parameters along with computational docking support the active site model, including plasticity and simple catalytic components. Although relatively uncomplicated, this catalytic machinery displays both stereoand chemical selectivity. The organophosphate pesticide paraoxon is hydrolyzed by covalent catalysis with rate-limiting dephosphorylation. This reactibody is, therefore, a kinetically selected protein template that has enzyme-like catalytic attributes.
Igs offer a versatile template for combinatorial and rational design approaches to the de novo creation of catalytically active proteins. We have used a covalent capture selection strategy to identify biocatalysts from within a human semisynthetic antibody variable fragment library that uses a nucleophilic mechanism. Specific phosphonylation at a single tyrosine within the variable light-chain framework was confirmed in a recombinant IgG construct. Highresolution crystallographic structures of unmodified and phosphonylated Fabs display a 15-Å-deep two-chamber cavity at the interface of variable light (V L ) and variable heavy (V H ) fragments having a nucleophilic tyrosine at the base of the site. The depth and structure of the pocket are atypical of antibodies in general but can be compared qualitatively with the catalytic site of cholinesterases. A structurally disordered heavy chain complementary determining region 3 loop, constituting a wall of the cleft, is stabilized after covalent modification by hydrogen bonding to the phosphonate tropinol moiety. These features and presteady state kinetics analysis indicate that an induced fit mechanism operates in this reaction. Mutations of residues located in this stabilized loop do not interfere with direct contacts to the organophosphate ligand but can interrogate second shell interactions, because the H3 loop has a conformation adjusted for binding. Kinetic and thermodynamic parameters along with computational docking support the active site model, including plasticity and simple catalytic components. Although relatively uncomplicated, this catalytic machinery displays both stereoand chemical selectivity. The organophosphate pesticide paraoxon is hydrolyzed by covalent catalysis with rate-limiting dephosphorylation. This reactibody is, therefore, a kinetically selected protein template that has enzyme-like catalytic attributes.
catalytic antibodies | crystal structure | insecticide | organophosphate hydrolysis E nzymes achieve extraordinary catalytic efficiencies by coordinating binding forces and reactive residues within their active sites to alter the mechanism and energy landscape of a chemical reaction (1, 2) . This functional complexity poses a challenge for approaches to create artificial enzyme-like catalysts. The interplay between binding and catalysis can be explored through directed evolution strategies (3) . Simple enzymatic activities have been developed by adaptation of a protein template for binding to stable analogs of substrates or transition states (TSA), which was exemplified by the generation of a broad array of catalytic antibodies (4) (5) (6) , and some of these anti-TSA antibodies use a nucleophilic residue in their catalytic mechanism (7) . This approach has only exceptionally been directed to recruit residues that participate in covalent catalysis that can be considered essential for multistep catalytic efficiency (8). However, aldolase antibodies obtained by reactive immunization display among the most efficient de novo generated protein catalytic activity yet reported, and structural studies of these antibodies have shown how their binding mechanism allows for discontinuous evolution of a promiscuous catalytic site (9, 10) .
Selection by reversible covalent binding is compatible with conventional affinity maturation, where the protein environment provides thermodynamic stabilization of the covalent adduct. Alternatively, irreversible covalent binding allows for kinetic selection, favoring sites that accelerate bond formation by transition state stabilization. In a classical example, serine hydrolases catalyze phosphorylation of their active site as a result of the specifically enhanced reactivity of the nucleophilic serine-195 (chymotrypsinogen numbering system) (11) . We have sought to use such enhanced reactivity for the generation of a reactibody. It is, thus, evident that innate reactivity can be deployed to capture more highly evolved biocatalysts that conserve an essential residue for covalent catalysis (12) . Mechanism-based kinetic selection may, thus, be differentiated from suicide substrate selection or similar strategies that have successfully used covalent capture (13) . We previously applied this approach to selection of a diversified repertoire of human Ig variable light (V L ) and variable heavy (V H ) single-chain fragments (scFv) displayed on phage particles (14) . Using a biotinylated phosphonate ester (1a) (Fig. 1) for solution phase modification, we identified a set of nucleophilic scFv encompassing sites predisposed for covalent catalysis. Sequence analysis of the reactive clones revealed preferred pairing of λ-V L and V H chains with conserved heavy chain complementary determining region 3 (CDR-H3) sequences. Two structural motifs were seen using distinct tyrosine residues in V L as nucleophile. Of these clones, seven of eight clones had a tyrosine (Y-L33) residue within CDR1 as a putative nucleophile. However, the most nucleophilically active clone, A.17, used a tyrosine residue (Y-L37) in a conserved framework (FR2), a clear expansion of the conventional concept of a binding site. The term reactibody is proposed Author contributions: I.S., A.A.B., N.P., A.F., A.T., and A.G. designed research; I.S., I.K., V.A.M., N.K., and A.R. performed research; E.C., F.N., Y.N., V.A.M., H.D., B.A., N.K., and A.A.M. contributed new reagents/analytic tools; I.S., E.C., I.K., F.N., Y.N., V.A.M., H.D., B.A., A.A.B., N.K., A.R., P.M., A.G.T., N.P., A.A.M., A.F., A.T., and A.G. analyzed data; and I.S., I.K., A.A.B., P.M., A.F., A.T., and A.G. wrote the paper. here to denote a protein template selected for chemical reactivity rather than ground state binding.
Results and Discussion
To facilitate efforts to elucidate structure-function correlation of the selected reactibodies, the V L and V H elements of A.17 were reconstructed for expression as full-length IgG in Chinese Hamster Ovary (CHO) cells (Fig. S1 ). The apparent nucleophilic reactivity of the scFv A.17 was retained in the whole IgG construct, which was determined using kinetic studies with phosphonate substrate 1b (Fig. 1) . Analysis of the kinetic data for reaction between IgG A.17 and 1b, using DYNAFIT software (15) , is compatible with a kinetic model proceeding through a single noncovalent intermediate before the rate-determining covalent step (1) . Calculation of the dissociation constant (K D , step 1) and rate constant for A.17 phosphonylation (k 2 , step 2) revealed a catalytic efficiency similar to the efficiency of serine proteases reacting with phosphonate ester inactivators (16) .
Although hydrolytic turnover was not observed, the reaction scheme can be extended to include a step for hydrolysis of the intermediate to regenerate the nucleophilic tyrosine (step 3), and structural studies can be implemented to provide a rational design basis to implement this step (1):
where Re Ab = reactibody, X = leaving group, and Nu = water/ nucleophile. To clarify the molecular mechanism of the machinery of the reactibody, crystal structures of the native A.17 Fab (Protein Data Bank accession code 2XZA) and its product modified by reaction with 1b (Protein Data Bank accession code 2XZC) have been solved at 1.5-and 1.36-Å resolution, respectively (Table S1 ). These structures reveal a deep cavity at the interface between V L (three β-sheets) and V H (four β-sheets) with several striking features ( Fig.  2 and Movie S1). Most notably, the antigen-binding site seems to be subdivided into upper and lower chambers ( Fig. 2 A-C) , each chamber formed from V H and V L residues. The upper chamber ( Fig. 2A) , defined primarily by five tyrosines (Y-H33, Y-H53, Y-H59, Y-L33, and Y-L50) plus tryptophan W-L92 (Fig. 2D) , is analogous to a specific tyrosine cluster typical of antibodies interacting with DNA or other phosphoryl esters (17, 18) . An opening at W-L92, Y-H34, and N-H105 leads to a lower chamber consisting primarily of framework residues. Reactive Y-L37 forms the base of the chamber ( Fig. 2B ) with its side chain packed against F-L100, W-H48, and W-H109, which orientates the hydroxyl group of Y-L37 into the cavity at a depth of 15 Å from the surface. Within this subsite, main chain atoms of G-H90/T-H91 and side chains of S-L35, W-L92, P-L98, and F-L100 form a niche for the phenyl group of the phosphonate ester, whereas H-N105 provides an H bond to the pseudotropine nitrogen in the OP-A.17 structure ( The light chain is shown in gray, the heavy chain is in blue, the V H loop is in magenta, and the OP molecule is in green. Key residues are represented as sticks, with nitrogen atoms marked by deep blue, oxygen atoms marked by red, and phosphorus marked by orange. A bound chloride ion, indicated by the green sphere, is constant to modification (Fig. S3A ).
2E
). The dimensions and topology of the site are atypical of antibodies in general, including catalytic antibodies, which are illustrated in Fig. 3 (19) (20) (21) . The reactive nucleophile is farther from the protein surface than the corresponding group in an aldolase antibody (15 vs. 13 Å). The depth and structure of the pocket may be compared qualitatively with the catalytic sites of cholinesterases ( Fig. 3 ) (22) (23) (24) .
Differences in the structure of native and 1b-modified reactibody suggest that considerable conformational rearrangement accompanies ligand migration into the site (Fig. 4A) . Basically, there are two primary models of the mechanism of conformational change because of antibody-ligand interactions: the existence of preequilibrium conformers and an induced fit mechanism (25) (26) (27) . Conformational rearrangements of reactibody A.17 have been examined by both structural methods and kinetic approaches to obtain a model that best fits one of these modes.
Structural analyses revealed significant differences between crystal structures of unmodified and phosphonylated antibodies. Residues L99-G110 of HCDR3 seem to define a conformationally mobile element that spans the upper and lower chambers, with key residues A-H107 and W-H109 oriented into the cavity (Fig. 2E) . In the unmodified structure, this solvent-exposed loop is highly disordered, with a B factor of 40-50 Å 2 compared with an overall B factor of 19 Å 2 . By contrast, the electron density map at these residues in OP-A.17 is well-defined, with B factors ranging from 15 to 25 Å 2 ( Fig. S2 ). Additional displacements are required at H-H104 (3.05 Å), N-H105 (3.63 Å), A-H107 (0.70 Å), and W-H109 (0.86 Å) to accommodate the ligand and permit strong H bonding (2.79 Å) between the main-chain oxygen of N-H105 and the pseudotropine nitrogen (Figs. 2E and 4A ). Significant displacements in the L-chain, including a 20°χ 2 angle rotation and 0.4-Å shift at W-L92 and a 10°rotation at Cα of F-L100, enable nesting of the phenyl ring of 1b with T-stacking interactions with the ligand. These motions may be concerted with a 5°r otation of the Y-L37 side chain. These observed conformational rearrangements support the existence of an induced fit-like mechanism during the ligand-antibody interaction. A cloud of electron density just above the face opposite to the Y-L37-OP bond was modeled as a cluster of mobile water molecules. Y-H34 participates in an H-bonding network stabilizing this cluster (Fig.  4B) . The phosphonyl oxygen is strongly H-bonded to water w614 (2.55 Å), suggesting polarization of the P-O bond to enhance electrophilicity (Fig. 2E) . In unmodified A.17, a network of water molecules (w689, w688, and w274) bridges the hydroxyl group of S-L35 to N-H105 (Fig. S4) . Conversely, transfer of the OP substrate into the lower compartment must break this network and displace these water molecules.
In order to further assess interactions in the protein environment, thermodynamic parameters for the reaction of A.17 and selected mutants with 1b were measured by isothermal titration calorimetry (ITC) (Fig. S5A) . The data were fitted to theoretical binding curves assuming a single ligand site. In case of A.17 both entropy and enthalpy of reaction were favorable, with ΔH decreasing threefold as temperature increased from 10°C to 37°C (Table 1 ). The observed enthalpy changes and apparent
were in line with ITC-estimated parameters for antibodies binding to their haptens (28) . Furthermore, a theoretical ΔH of −2.56 kcal/ mol for computational docking of 1b from the surface to the lower chamber is in good correspondence with the experimental value of −2.78 kcal/mol (Fig. S6 and Movie S2).
Mutants Y-L33F and Y-L37F of A.17 IgG probe two possible nucleophilic residues identified in scFv reactibodies (14) . Consistent with previous studies and the X-ray structure, only Y-L37F results in loss of reactivity. The ΔH and K D † of A.17 and ΔH and K D of the inactive mutant A.17 Y-L37F interacting with 1b (Fig. S5B) were nearly identical and within a factor of two of the respective factors for the BChE reaction (Table 1 and Fig. S5C) . A very small enthalpy change might be expected for the ester exchange reaction where a P-OAr bond is broken and another formed to a tyrosine residue (or to a serine residue in the case of BChE). A similar effect has been described in calorimetric studies of horse serum BChE inhibition by 5 (29). The covalent reaction of A.17 must also reflect free energies caused by noncovalent interactions stabilizing the adduct and free energies caused by release of the leaving group. The latter energy change seemed to be negligible and was estimated in reference experiments of p-nitrophenol binding to native or chemically modified A.17 (Fig. S5D ). These observations suggest that the thermodynamic changes are sensitive primarily to noncovalent interactions. Accordingly, changes in heat capacity because of binding, calculated from the temperature dependence of enthalpy changes (Fig. S5E) , were used to estimate the change in solvent accessible area (30) using the following empirical formula (Eq. 2):
where ΔA ar and ΔA nonar are the protected areas in angstroms squared because of formed by aromatic and nonaromatic residues, respectively (31). Because covalently bound OP is effectively buried in the cavity, these changes can be attributed to conformational In each case, the distance measured is the height of a pyramid with a triangle base constructed on the three residues nearest to the entrance of the active site, and apexes are the residue nearest to the ligand. (Fig. S4) .
changes at the protein surface. The ΔSAA of −175 to −260 Å 2 calculated from ITC is comparable with ΔSAA of −240 Å 2 calculated from the crystal structures. In contrast to A.17WT, the ΔH of the Y-L37F interaction with 1b is independent of temperature, suggesting slight conformational changes in case of incubation of the Y-L37F antibody with 1b (Fig. S5E) .
Mutants N-H105A and H-H104A were also generated to investigate the role of the conformationally flexible CDR-H3 loop on reactivity. These mutations do not interfere with direct contacts to the OP ligand but can interrogate second shell interactions as the CDR-H3 loop adjusts for binding. ITC data show similar K D † but differing contribution of ΔH and ΔS for the reactions of 1b with A.17WT and A.17 H-H104A, where the latter reaction is enthalpically more favorable (Table 1 and Fig. S5F ). The effect of both mutations on the kinetically determined K D is also minimal, whereas the rate constant k 2 decreases 2.4-fold in H-H104A and increases 1.3-fold in N-H105A (Table 2) . Thus, mutations within the H3 loop influence the pseudofirst order reaction rate without significantly altering the binding step 2 [1] . These results support an active site model where H3 loop dynamics allow penetration of reactant from outer to inner chambers. The H-H104 side chain toggles between intrachain H bonds to D-H106 in unmodified A.17 and to T-H100 in A.17-OP (Fig. S7) . The H-H104A substitution may increase H3 conformational freedom but also can impair induced fit by destabilizing a conformation favored in the product. The N-H105 side chain participates in H bonding to the water bridge with Y-L37 in the unmodified structure (Fig. S4) . N-H105A weakens this lattice, which could facilitate displacements for insertion of substrate into the reactive center. Based on these observations and data from crystallographic analysis, we suggest that covalent modification of reactibody A.17 by 1b can be described by an induced fit model. To clarify this model, we carried out presteady state kinetic investigations of fluorescence changing during the phosphonylation reaction. According to steady state kinetics, the minimal kinetic scheme of the reaction includes stages 1 and 2 of equation 1 (Fig. 5A) . The conformational fluctuations of Ab were monitored through intrinsic tryptophan fluorescence changing during binding of phosphonate molecule to A.17. We observed a single increase in tryptophan fluorescence in a 100-ms time range (Fig. 5B Left) . The direct dependence of k obs on substrate concentration suggests the prevalence of an induced fit mechanism in the reaction of A.17 with phosphonate 1b (Fig. 5B  Right) (25) . Overall, our balanced view is that the evidence favors an induced fit-like model, whereas we can accept that, over the wide range of conditions that we have used, a significant fraction of the flux can occur through both pathways, resulting in a mixed mechanism for this reaction (32) .
The efficiency of A.17 reacting with 1b is more than an order of magnitude greater than the corresponding BChE reaction (Table  2) , and it compares favorably with typical rates of serine protease modification by phosphonate 1b (16, 33, 34 ). This kinetic advantage is a clear demonstration that the complementary matching of the shape and chemical reactivity of substrate 1b with the selected reactibody exceeds the performance of an enzyme such as BChE with a classical phosphorylating agent. Enzyme selectivity for the phosphonate structure may also distort these comparisons (33) (34) (35) (36) . Reactive phosphoesters diisopropyl fluorophosphate (DFP) (2), paraoxon (5), and 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF) (3) inhibited A.17 reaction with 1a, whereas echothiophate (4) had no effect at concentrations up to 10 mM (Fig. 6A and Figs. S3B and S8A). These molecules may be excluded from the reactive center while binding with varying affinities to the outer site. Stereoselective S N 2 reaction with the R P enantiomer of 1b was deduced from the configuration at phosphorus in the A.17-OP adduct. Rate constants could be higher by a factor of two if the S P enantiomer does not react or even more if it is an inhibitor. Over a longer time span, hydrolysis of paraoxon 5 was detected, suggesting that a smaller OP molecule can access the lower chamber in a productive orientation. Moreover, p-nitrophenol product was released in molar excess to active sites (Fig. S8B) , and the hydrolysis rate was linearly dependent on A.17 concentration (Fig. S3C) . The reaction rate also increased linearly with hydroxylamine concentration (Fig. 6B) , whereas mutant Y-L37F had no activity (Fig. S3D ). These observations strongly support a reaction mechanism that proceeds through a phosphotyrosine covalent intermediate at Y-L37. Elementary rate constants of the reaction (k 2 = 1.1 ± 0.1 × 10
, and k 4 = 1.26 ± 0.09 × 10
) were estimated where dephosphorylation is rate limiting (Fig. 6B) . Interaction between A.17 and paraoxon leads to the accumulation of the covalent intermediate according to the kinetic data. The existence of the covalent intermediate, supporting the covalent catalysis mechanism for paraoxon hydrolysis by the A.17 reactibody, was also proved by MS analysis showing the existence of phosphorylated antibody (Fig. S8C) .
By contrast, the A.17Y-L37-OP ester obtained from reaction with 1b was stable to hydrolysis under both native and denaturing conditions, whereas hydroxylamine (1-100 mM) had no influence on the observed rate (Fig. S3E) . Monoisonitrosoacetone, a classical cholinesterase reactivator, also failed to regenerate A.17 reactivity. Thus, notwithstanding their chemical similarity, the two A.17 phosphoesters show quite different P-O bond stability, suggesting that the active site assists hydrolysis of the intermediate generated from 5. Although the mechanism remains speculative and the rate of the phosphate release is slow, these data show that a pathway is available for catalytic turnover, which is described by equation 1.
The enhanced reactivity of amino acid residues used in covalent catalysis is an inherent function of the structured environment within the enzyme active site. Reactive selection shows how architectures that support efficient chemistry can arise from relatively minor alterations of the protein interior. Studies of aldolase antibodies obtained by reactive immunization suggested the reactive nucleophile could emerge from a single mutation releasing a lysine side chain constrained in a hydrophobic environment by a salt bridge or H bond (10, 21) . The A.17 reactibody reveals an alternative solution to reorganizing available structures for re- activity. In antibody structures, Y-L37 is invariably buried at the V L -V H interface, where it packs against W-H109 (103) and adjacent residues at the base of CDR-H3 (e.g., Cr6361, Protein Data Bank 3GBM, 85% V L homology; E51, Protein Data Bank 1RZF, 84% V L homology). By contrast, a long and flexible H3 loop in A.17 allows sufficient displacement at its base to open a chamber directly above the Y-L37 side chain. It is worth noting that H3 sequences were synthetically diversified in the scFv library from which A.17 was derived (37) . It is conceivable that this diversity encompasses sequences that are rare or prohibited in a natural repertoire. The disordered H3 loop in unmodified A.17 seems to act as a flexible wall of the cavity to facilitate migration of ligand into the lower chamber. Moreover, compression and stabilization of the phosphonylated protein, evident from both the structure analysis and ITC studies, were indicative of a correlation between reactivity and protein dynamics, and they suggest that structural plasticity is a selected feature. Conformational changes in antibody binding are not uncommon and may be seen with protein antigens where flexibility can optimize multiple interactions over a large antibodyantigen interface. However, antibodies elicited against haptens or other small ligands show evidence of diminishing V-region plasticity, because somatic mutations serve to anchor topologies suitable for ligand complementarity (38, 39) . Plasticity encoded in the V germline is thought to amplify combinatorial diversity, because various shapes could be imprinted on each template. Accordingly, affinity maturation favors more rigid protein structures and may preclude dynamic features in enzymatic function. By contrast, kinetic selection may exploit protein dynamics, exposing reactive residues in the protein interior. It is remarkable that motions deep within the pocket also enhance substrate complementarity. Although it is possible that a favorable enthalpy of chemical reaction drives these displacements, the similar free energy of binding to a chemically inert Y-L37F mutant suggested that noncovalent interactions may promote conformational changes for a productive Michaelian complex. Collectively, our observations provide a compelling case for coupling between dynamics of the cavity and reactivity at the tyrosine side chain.
Details of the structure capable of revealing interactions with a putative trigonal bipyramidal transition state for ester exchange and a trajectory for the leaving group are not evident from the structures analyzed herein. However, small adjustments in contact residues are clearly capable of accommodating such a transition state. The water cluster opposite the new P-O bond in the complex may also play a role, and one water molecule is poised to hydrolyze the phosphotyrosine ester to achieve turnover. Although there is no evidence that the site can activate this water for such nucleophilic attack, a mechanism must be available to accomplish the observed hydrolysis of the intermediate formed by reaction with paraoxon 5. Possibly, the site is locked in the case of reaction with 1b, whereas the interaction with 5 allows dynamic displacements for the second-step reaction. Additional studies to clarify this question may uncover possible means of improving the observed catalytic efficiency.
We set out to show that kinetic selection for covalent reactivity can identify protein sites correctly configured for development of artificial biocatalysts. Our thermodynamic and structural analyses unexpectedly revealed an associated feature with broader implications. Recently, the question of how enzymes harness protein dynamics for catalytic efficiency has been revisited through structural and computational approaches (1, 40) . Coupled conformational substates optimized to admit or release substrates or organize the active site for catalysis have been described (41) .
Reactibodies can present unique cavities that facilitate simple chemical processes and provide a useful model for how proteins can acquire these adaptations. Strategies to deploy antibodies as enzymes have been criticized on the grounds that an Ig template cannot deploy residues for covalent catalysis and that it lacks the flexibility required for dynamic mechanisms. Reactive immunization and kinetic selection have provided evidence to dispel these concerns. At the same time, our reactibody template has proved adaptable in ways that may apply also to other protein scaffolds.
Methods
Crystallization of FabA.17 and OP-FabA.17. The purified A.17 Fab fragment (9 mg/mL) was crystallized using the hanging drop method. Diffraction data were collected at the European Synchrotron Radiation Facility on ID14-eh4 beam line using λ = 0.979-Å wavelength with ADSC Quantum 4 detector.
ITC. The thermodynamic parameters of A.17WT, A.17 mutants, or BChE from human plasma reacting with 1b or p-nitrophenol were measured on a MicroCal iTC200 instrument (MicroCal). Aliquots of ligands (2.5 μL) were injected into the 0.2-mL cell containing the protein solution in PBS buffer (pH 7.4) to achieve a complete binding isotherm. The resulting titration curves were fitted using MicroCal Origin software.
Evaluation of Kinetic Mechanism and Processing of Primary Data. Reactions of A.17WT and its mutants (3-32 μM) or highly purified BChE (3-10 μM) from human plasma with 1b (or 5) at concentrations ranging from 10 to 500 μM were carried out in 0.1 M phosphate buffer (pH 7.4) at 25°C. Stopped-flow measurements with fluorescence detection were carried out using a model SX.18MV stopped-flow spectrometer (Applied Photophysics). The Ab concentration was fixed at 3 μM, and the concentration of 1b was varied from 1 to 50 μM. Nucleophile competition in the presence of NH 2 OH at concentrations ranging from 0 to 100 mM is carried out under the same reaction conditions with background correction.
ESI-FTICR-MS (Top Down)
. The A.17 antibody (10 μM) was incubated with 5 (paraoxon; 2 mM in 0.1 M phosphate buffer, pH 7.4) at 37°C for 16 h. Samples were analyzed directly using ESI-MS with a Bruker APEX Ultra FTICR mass spectrometer (Bruker Daltonics).
